Literature DB >> 26410757

PHEA-PLA biocompatible nanoparticles by technique of solvent evaporation from multiple emulsions.

Gennara Cavallaro1, Emanuela Fabiola Craparo2, Carla Sardo3, Gaetano Lamberti4, Anna Angela Barba5, Annalisa Dalmoro6.   

Abstract

Nanocarriers of amphiphilic polymeric materials represent versatile delivery systems for poorly water soluble drugs. In this work the technique of solvent evaporation from multiple emulsions was applied to produce nanovectors based on new amphiphilic copolymer, the α,β-poly(N-2-hydroxyethyl)-DL-aspartamide-polylactic acid (PHEA-PLA), purposely synthesized to be used in the controlled release of active molecules poorly soluble in water. To this aim an amphiphilic derivative of PHEA, a hydrophilic polymer, was synthesized by derivatization of the polymeric backbone with hydrophobic grafts of polylactic acid (PLA). The achieved copolymer was thus used to produce nanoparticles loaded with α tocopherol (vitamin E) adopted as lipophilic model molecule. Applying a protocol based on solvent evaporation from multiple emulsions assisted by ultrasonic energy and optimizing the emulsification process (solvent selection/separation stages), PHEA-PLA nanostructured particles with total α tocopherol entrapment efficiency (100%), were obtained. The drug release is expected to take place in lower times with respect to PLA due to the presence of the hydrophilic PHEA, therefore the produced nanoparticles can be used for semi-long term release drug delivery systems.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  1,1′-Carbonyldiimidazole—CDI: PubChem CID: 68263; Amphiphilic polymer; Biocompatible polymer; Diethylamine—DEA: PubChem CID: 8021; Drug delivery; Emulsions; Ethanolamine: PubChem CID: 700; N,N′-dimethylformamide—DMF: PubChem CID: 6228; Nanoparticles; PHEA–PLA; Poly-lactic acid—PLA: PubChem CID: 612; Polysuccinimide—PSI: PubChem CID: 5960; Polyvinyl alcohol—PVA: PubChem CID: 11199; Ultrasonic energy; α,β-Poly(N-2-hydroxyethyl)-dl-aspartamide—PHEA: PubChem CID: 155399; α-Tocopherol: PubChem CID: 14985

Mesh:

Substances:

Year:  2015        PMID: 26410757     DOI: 10.1016/j.ijpharm.2015.09.050

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  5 in total

1.  Evaluation of optimum conditions for pachyman encapsulated in poly(d,l-lactic acid) nanospheres by response surface methodology and results of a related in vitro study.

Authors:  Sisi Zheng; Li Luo; Ruonan Bo; Zhenguang Liu; Jie Xing; Yale Niu; Yuanliang Hu; Jiaguo Liu; Deyun Wang
Journal:  Int J Nanomedicine       Date:  2016-09-23

2.  Polyaspartamide-Based Nanoparticles Loaded with Fluticasone Propionate and the In Vitro Evaluation towards Cigarette Smoke Effects.

Authors:  Emanuela Fabiola Craparo; Maria Ferraro; Elisabetta Pace; Maria Luisa Bondì; Gaetano Giammona; Gennara Cavallaro
Journal:  Nanomaterials (Basel)       Date:  2017-08-13       Impact factor: 5.076

3.  Drug-interactive mPEG-b-PLA-Phe(Boc) micelles enhance the tolerance and anti-tumor efficacy of docetaxel.

Authors:  Feirong Gong; Rongrong Wang; Zhengquan Zhu; Jiayao Duan; Xin Teng; Zhong-Kai Cui
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

4.  Recuperating Biopharmaceutical Aspects of Amphotericin B and Paromomycin Using a Chitosan Functionalized Nanocarrier via Oral Route for Enhanced Anti-leishmanial Activity.

Authors:  Shabi Parvez; Ganesh Yadagiri; Archana Karole; Om Prakash Singh; Anurag Verma; Shyam Sundar; Shyam Lal Mudavath
Journal:  Front Cell Infect Microbiol       Date:  2020-10-15       Impact factor: 5.293

5.  Inulin-g-poly-D,L-lactide, a sustainable amphiphilic copolymer for nano-therapeutics.

Authors:  Carla Sardo; Teresa Mencherini; Carmela Tommasino; Tiziana Esposito; Paola Russo; Pasquale Del Gaudio; Rita Patrizia Aquino
Journal:  Drug Deliv Transl Res       Date:  2022-02-22       Impact factor: 5.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.